Detalhe da pesquisa
1.
Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study.
J BUON
; 23(6): 1583-1590, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610781